Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Piotr Damiański
Observed name:
Piotr Damianski
Institution:
Medical University of Lodz
Observed institution:
Medical University of Lodz
ORCID:
0000-0002-2131-8910
Observed ORCID:
0000-0002-2131-8910
OpenAlex ID:
A5001301558
Monoclonal antibodies in the management of asthma: Dead ends, current status and future perspectives
2022
·
Grzegorz Kardas
, Michał Panek
, et al.
·
Frontiers in Immunology
·
70
PDF
Pathway to Remission in Severe Asthma: Clinical Effectiveness and Key Predictors of Success with Benralizumab Therapy: A Real-Life Study
2025
·
Piotr Damiański
, Adam Jerzy Białas
, et al.
·
Biomedicines
·
15
PDF
Neprilysin Inhibitors as a New Approach in the Treatment of Right Heart Failure in the Course of Chronic Obstructive Pulmonary Disease
2018
·
Maciej Liczek
, Iga Panek
, et al.
·
Advances in respiratory medicine
·
9
PDF
Neprilysin Inhibitors as a New Approach in the Treatment of Right Heart Failure in the Course of Chronic Obstructive Pulmonary Disease. Response to the Letter of Siniorakis et al.
2018
·
Maciej Liczek
, Iga Panek
, et al.
·
Advances in respiratory medicine
·
8
PDF
Improving the risk-to-benefit ratio of inhaled corticosteroids through delivery and dose: current progress and future directions
2021
·
Piotr Damiański
, Grzegorz Kardas
, et al.
·
Expert Opinion on Drug Safety
·
6
Clinical profiles of patients referred for biological therapy and major limitations in the qualification paths in a specialist asthma centre
2023
·
Piotr Damiański
, Dorota Podolska
, et al.
·
Advances in Dermatology and Allergology
·
3
PDF
Correction: Damiański et al. Pathway to Remission in Severe Asthma: Clinical Effectiveness and Key Predictors of Success with Benralizumab Therapy: A Real-Life Study. Biomedicines 2025, 13, 887
2025
·
Piotr Damiański
, Adam Jerzy Białas
, et al.
·
Biomedicines
·
2
PDF
Anti–IL-5 pathway therapy leads to marked reductions in circulating eosinophil activation and selective changes in remodeling-related biomarkers in severe eosinophilic asthma
2026
·
Piotr Damiański
, Anna Kumor-Kisielewska
, et al.
·
European Respiratory Journal
Impact of IL-5 Pathway Inhibition on Circulating Eosinophil- and Remodeling-Related Biomarkers in Severe Eosinophilic Asthma
2026
·
Piotr Damiański
, Anna Kumor-Kisielewska
, et al.
·
Journal of Asthma and Allergy
PDF
Organ Involvement and Constitutional Symptoms in Idiopathic Hypereosinophilic Syndrome: A 72-Patient Single-Centre Cohort
2026
·
Piotr Łacwik
, Izabela Kupryś-Lipińska
, et al.
·
Journal of Clinical Medicine
PDF
NEXThaler® in Focus: Evaluating Inhalers’ Expectations, Experiences, and Preferences Across Patients, General Practitioners, and Specialists
2025
·
Piotr Damiański
, Maciej Wojakiewicz
, et al.
·
Journal of Clinical Medicine
PDF
Inhaler Selection in Clinical Practice: Contrasting Perceptions and Experiences of General Practitioners and Specialists in Inhalation Therapy
2025
·
Piotr Damiański
, Maciej Wojakiewicz
, et al.
·
European Respiratory Journal
The many faces of hypereosinophilic syndrome: A multidisciplinary challenge. Insights from a large cohort study
2025
·
Piotr Lacwik
, Youssef Sleiman
, et al.
·
European Respiratory Journal
Disease remission in severe asthma patients on mepolizumab treatment and its duration after treatment discontinuation.
2023
·
Piotr Damiański
, Piotr Kuna
, et al.
·
European Respiratory Journal
Generalized emphysema and chronic obstructive pulmonary disease in a farmer, non-smoker - the more we seek, the more we find.
2019
·
Piotr Damiański
, Piotr Kuna
, et al.
·
PubMed
Inhibitory neprylizyny jako nowe podejście w leczeniu prawokomorowej niewydolności serca w przebiegu przewlekłej obturacyjnej choroby płuc
2019
·
Maciej Liczek
, Iga Panek
, et al.
·
Advances in respiratory medicine
PDF
Show more works
View as search
Works count:
16
Citation count:
113
H-index:
5
I10-index:
2
Year
Topic
Type